Hospital of the Montreal Sacre-Coeur
Junbel Makhzum
The Applanation Tonometry in Giant Cell Arteritis (ATOM-GCA) study will answer the following questions: 1. How does PWV, measured by applanation tonometry of temporal arteries, differ between patients with and without a final diagnosis of GCA (based on pre-defined criteria 6 months after inclusion)? 2. What is the diagnostic accuracy and positivity cutoff of the PWV, measured by applanation tonometry, in detecting: 1. A clinical diagnosis of GCA (based on pre-defined criteria 6 months after inclusion)? 2. Inflammation of temporal arteries on high-resolution ultrasound? 3. What is the acceptability and adherence of repeat applanation tonometry during the follow-up period in patients with GCA?
Giant Cell Arteritis
Applanation tonometry
Standardized GCA assessment
Repeat applanation tonometry (optional)
ATOM-GCA is a single-center, cross-sectional vanguard study.
Study Type : | OBSERVATIONAL |
Estimated Enrollment : | 146 participants |
Official Title : | The Applanation Tonometry in Giant Cell Arteritis Pilot |
Actual Study Start Date : | 2026-01 |
Estimated Primary Completion Date : | 2026-10 |
Estimated Study Completion Date : | 2027-03 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 50 Years to 99 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Vasculitis Clinic, Hospital of the Sacre-Coeur de Montreal
Montreal, Quebec, Canada, H4J1C5